Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis-Reference-Cited by-同舟云学术

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

Published:2010-08-04 Issue:43 Volume:2 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Pinnix Zandra K.¹,Miller Lance D.²³,Wang Wei²,D’Agostino Ralph³⁴,Kute Tim⁵,Willingham Mark C.³⁵,Hatcher Heather²,Tesfay Lia²,Sui Guangchao²,Di Xiumin²,Torti Suzy V.¹³,Torti Frank M.²³

Affiliation:

1. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

2. Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

3. Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

4. Department of Biostatistics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

5. Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

Abstract

An iron efflux pump is a pivotal protein in breast cancer biology and a strong and independent predictor of breast cancer prognosis.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference54 articles.

1. Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: Possible regulation mechanism

2. The Role of Iron Chelation in Cancer Therapy

3. A precious metal: Iron, an essential nutrient for all cells

4. Tumorigenic Properties of Iron Regulatory Protein 2 (IRP2) Mediated by Its Specific 73-Amino Acids Insert

5. Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts

Cited by 303 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferritinophagy: Molecular mechanisms and role in disease;Pathology - Research and Practice;2024-10

2. Ferroptosis-targeting drugs in breast cancer;Journal of Drug Targeting;2024-09-05

3. Self-enhanced targeted nanomedicines based on iron starvation acclimation for tumor-specific therapy;Chemical Engineering Journal;2024-09

4. Immunometabolism of ferroptosis in the tumor microenvironment;Frontiers in Oncology;2024-08-12

5. Hypoxia‐inducible factor‐1α can reverse the Adriamycin resistance of breast cancer adjuvant chemotherapy by upregulating transferrin receptor and activating ferroptosis;The FASEB Journal;2024-08-09